How much did Instem achieve in EBIT for the current year?
In the current year, Instem has achieved an EBIT of 11.54 M GBP.
Instem EBIT 2024
Instem EBIT
11.54 M GBP
Ticker
INS.L
ISIN
GB00B3TQCK30
WKN
A1C7NS
In 2024, Instem's EBIT was 11.54 M GBP, a 27.27% increase from the 9.06 M GBP EBIT recorded in the previous year.
The Instem EBIT history
| YEAR | EBIT (undefined GBP) |
|---|---|
| 2026e | 21.27 |
| 2025e | 14.52 |
| 2024e | 11.54 |
| 2023e | 9.06 |
| 2022 | 6.5 |
| 2021 | 4.77 |
| 2020 | 3.81 |
| 2019 | 2.83 |
| 2018 | 2.38 |
| 2017 | 0.82 |
| 2016 | 0.05 |
| 2015 | 1.34 |
| 2014 | 0.68 |
| 2013 | 0.96 |
| 2012 | 1.02 |
| 2011 | 1.57 |
| 2010 | 2.2 |
| 2009 | 2.14 |
| 2008 | 1.91 |
| 2007 | 1.77 |
Instem Revenue, EBIT, Net Income GB00B3TQCK30 · A1C7NS
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Instem, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Instem from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Instem’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Instem. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Instem’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Instem’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Instem’s growth potential.
Instem Revenue, EBIT and net profit per share
| Date | Instem Revenue | Instem EBIT | Instem Net Income |
|---|---|---|---|
| 2026e | 90.28 M undefined | 21.27 M undefined | 13.48 M undefined |
| 2025e | 84.1 M undefined | 14.52 M undefined | 11.65 M undefined |
| 2024e | 75.86 M undefined | 11.54 M undefined | 9.18 M undefined |
| 2023e | 67.21 M undefined | 9.06 M undefined | 7.27 M undefined |
| 2022 | 57.63 M undefined | 6.5 M undefined | 4.7 M undefined |
| 2021 | 46.02 M undefined | 4.77 M undefined | 1.68 M undefined |
| 2020 | 28.22 M undefined | 3.81 M undefined | 2.27 M undefined |
| 2019 | 25.72 M undefined | 2.83 M undefined | -920,000 undefined |
| 2018 | 22.71 M undefined | 2.38 M undefined | 1.47 M undefined |
| 2017 | 21.07 M undefined | 820,000 undefined | 640,000 undefined |
| 2016 | 18.32 M undefined | 50,000 undefined | 1.06 M undefined |
| 2015 | 16.32 M undefined | 1.34 M undefined | -430,000 undefined |
| 2014 | 13.43 M undefined | 680,000 undefined | 150,000 undefined |
| 2013 | 11.36 M undefined | 960,000 undefined | 530,000 undefined |
| 2012 | 10.66 M undefined | 1.02 M undefined | 1.04 M undefined |
| 2011 | 10.79 M undefined | 1.57 M undefined | 1.01 M undefined |
| 2010 | 10 M undefined | 2.2 M undefined | 900,000 undefined |
| 2009 | 9.99 M undefined | 2.14 M undefined | 1.71 M undefined |
| 2008 | 8.81 M undefined | 1.91 M undefined | -350,000 undefined |
| 2007 | 7.99 M undefined | 1.77 M undefined | 700,000 undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2007 | 7.99 M GBP | 1.77 M GBP | 700,000 GBP |
| 2008 | 8.81 M GBP | 1.91 M GBP | -350,000 GBP |
| 2009 | 9.99 M GBP | 2.14 M GBP | 1.71 M GBP |
| 2010 | 10 M GBP | 2.2 M GBP | 900,000 GBP |
| 2011 | 10.79 M GBP | 1.57 M GBP | 1.01 M GBP |
| 2012 | 10.66 M GBP | 1.02 M GBP | 1.04 M GBP |
| 2013 | 11.36 M GBP | 960,000 GBP | 530,000 GBP |
| 2014 | 13.43 M GBP | 680,000 GBP | 150,000 GBP |
| 2015 | 16.32 M GBP | 1.34 M GBP | -430,000 GBP |
| 2016 | 18.32 M GBP | 50,000 GBP | 1.06 M GBP |
| 2017 | 21.07 M GBP | 820,000 GBP | 640,000 GBP |
| 2018 | 22.71 M GBP | 2.38 M GBP | 1.47 M GBP |
| 2019 | 25.72 M GBP | 2.83 M GBP | -920,000 GBP |
| 2020 | 28.22 M GBP | 3.81 M GBP | 2.27 M GBP |
| 2021 | 46.02 M GBP | 4.77 M GBP | 1.68 M GBP |
| 2022 | 57.63 M GBP | 6.5 M GBP | 4.7 M GBP |
| 2023e | 67.21 M GBP | 9.06 M GBP | 7.27 M GBP |
| 2024e | 75.86 M GBP | 11.54 M GBP | 9.18 M GBP |
| 2025e | 84.1 M GBP | 14.52 M GBP | 11.65 M GBP |
| 2026e | 90.28 M GBP | 21.27 M GBP | 13.48 M GBP |
Instem stock margins GB00B3TQCK30 · A1C7NS
The Instem margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Instem. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Instem.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Instem's sales revenue. A higher gross margin percentage indicates that the Instem retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Instem's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Instem's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Instem's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Instem. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Instem's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Instem Margin History
| Instem Gross margin | Instem Profit margin | Instem EBIT margin | Instem Profit margin |
|---|---|---|---|
| 2026e | 96.26 % | 23.56 % | 14.93 % |
| 2025e | 96.26 % | 17.27 % | 13.86 % |
| 2024e | 96.26 % | 15.21 % | 12.1 % |
| 2023e | 96.26 % | 13.49 % | 10.81 % |
| 2022 | 96.26 % | 11.27 % | 8.15 % |
| 2021 | 96.26 % | 10.37 % | 3.65 % |
| 2020 | 94.51 % | 13.5 % | 8.04 % |
| 2019 | 94.32 % | 11 % | -3.58 % |
| 2018 | 95.11 % | 10.48 % | 6.47 % |
| 2017 | 92.03 % | 3.89 % | 3.04 % |
| 2016 | 96.72 % | 0.27 % | 5.79 % |
| 2015 | 96.38 % | 8.21 % | -2.63 % |
| 2014 | 98.59 % | 5.06 % | 1.12 % |
| 2013 | 99.03 % | 8.45 % | 4.67 % |
| 2012 | 95.97 % | 9.57 % | 9.76 % |
| 2011 | 98.98 % | 14.55 % | 9.36 % |
| 2010 | 96.26 % | 22 % | 9 % |
| 2009 | 96.26 % | 21.42 % | 17.12 % |
| 2008 | 96.26 % | 21.68 % | -3.97 % |
| 2007 | 96.26 % | 22.15 % | 8.76 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2007 | 96.26 % | 22.15 % | 8.76 % |
| 2008 | 96.26 % | 21.68 % | -3.97 % |
| 2009 | 96.26 % | 21.42 % | 17.12 % |
| 2010 | 96.26 % | 22 % | 9 % |
| 2011 | 98.98 % | 14.55 % | 9.36 % |
| 2012 | 95.97 % | 9.57 % | 9.76 % |
| 2013 | 99.03 % | 8.45 % | 4.67 % |
| 2014 | 98.59 % | 5.06 % | 1.12 % |
| 2015 | 96.38 % | 8.21 % | -2.63 % |
| 2016 | 96.72 % | 0.27 % | 5.79 % |
| 2017 | 92.03 % | 3.89 % | 3.04 % |
| 2018 | 95.11 % | 10.48 % | 6.47 % |
| 2019 | 94.32 % | 11 % | -3.58 % |
| 2020 | 94.51 % | 13.5 % | 8.04 % |
| 2021 | 96.26 % | 10.37 % | 3.65 % |
| 2022 | 96.26 % | 11.27 % | 8.15 % |
| 2023e | 96.26 % | 13.49 % | 10.81 % |
| 2024e | 96.26 % | 15.21 % | 12.1 % |
| 2025e | 96.26 % | 17.27 % | 13.86 % |
| 2026e | 96.26 % | 23.56 % | 14.93 % |
Instem Aktienanalyse
What does Instem do?
Instem PLC is a company specialized in providing software solutions for the health and life sciences. It is headquartered in Abingdon, Oxfordshire and operates internationally. The company was founded in 2000 and has been listed on the London Stock Exchange since 2004. Instem's business model is based on helping life science companies optimize and automate their workflows. They offer a wide range of software products tailored to the specific needs of their customers. This includes systems for documenting animal experiments, clinical data collection, and solutions for regulatory drug submissions. One of Instem's key divisions is the Preclinical Solutions Division, which helps life science companies effectively plan and conduct their preclinical studies. The products in this division support the creation of study protocols, planning experimental procedures, and documenting study results. Additionally, customers of the Preclinical Solutions Division can access assistance with data collection and analysis, as well as comprehensive consulting services. Another important division of Instem is the Clinical Solutions Division, which supports clinical research facilities in conducting clinical trials. Their solutions include clinical data collection, study monitoring, and data submission to regulatory authorities. The Clinical Solutions Division also provides support for quality control and the production of statistical reports. Instem is also active in other areas, such as in vitro diagnostics and chemical approval. In these fields, the company offers a range of software solutions that aid in data collection, analysis, and reporting. A key factor that sets Instem apart from its competitors is its close collaboration with the life science community. The company works closely with customers, regulatory agencies, and interest groups to ensure that its products meet industry requirements and standards. In addition, the company has established close relationships with leading clinical and research institutions worldwide. In summary, Instem PLC is a significant provider of software solutions for the health and life sciences. The company has experienced impressive growth in recent years and strengthened its position in key market segments. Instem is well positioned to continue benefiting from the increasing demand for software solutions in the health and life sciences industry. Instem ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing Instem's EBIT
Instem's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Instem's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Instem's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Instem’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Instem stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Instem.
How has the EBIT of Instem developed in recent years?
The EBIT of Instem has increased by 27.273% increased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Instem?
The EBIT of Instem is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Instem pay?
Over the past 12 months, Instem paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Instem is expected to pay a dividend of 0 GBP.
What is the dividend yield of Instem?
The current dividend yield of Instem is .
When does Instem pay dividends?
Instem pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Instem?
Instem paid dividends every year for the past 0 years.
What is the dividend of Instem?
For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.
In which sector is Instem located?
Instem is assigned to the 'Health' sector.
Wann musste ich die Aktien von Instem kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Instem from 9/6/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 9/6/2024.
When did Instem pay the last dividend?
The last dividend was paid out on 9/6/2024.
What was the dividend of Instem in the year 2023?
In the year 2023, Instem distributed 0 GBP as dividends.
In which currency does Instem pay out the dividend?
The dividends of Instem are distributed in GBP.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Instem
Our stock analysis for Instem Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Instem Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
